-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The results of the seventh batch of national procurement have gradually landed, and 8 provinces (cities) have clarified the specific implementation time:
Henan: November 1, 2022
Qinghai: November 1, 2022
Gansu: November 15, 2022
Shanxi: November 20, 2022
Liaoning: 0:00 on November 20, 2022
Xinjiang Corps: November 2022
Hainan: around the end of November 2022
Shanghai: Expected in late November
On July 18, the National Joint Procurement Office announced the results of the seventh batch of national drug centralized procurement, and clarified that it will be officially implemented
in November 2022.
Recently, Qinghai and Shanxi provinces have successively issued documents to implement the results of the seventh batch of national procurement, and 8 provinces and cities have clarified the specific implementation time
.
in November 2022.
Recently, Qinghai and Shanxi provinces have successively issued documents to implement the results of the seventh batch of national procurement, and 8 provinces and cities have clarified the specific implementation time
.
Shanxi: November 20, 2022
On October 25, the Shanxi Provincial Medical Insurance Bureau issued the Notice on Fully Implementing the Selection Results of the Seventh Batch of State-Organized Centralized Drug Procurement, clarifying that the results of the seventh batch of national procurement will be implemented from November 20, 2022
.
.
The scope of institutions involved includes all public medical institutions, military medical institutions, and voluntary participation in medical insurance designated social medical institutions and designated pharmacies
.
.
The agreed procurement volume and procurement cycle of the seventh batch of selected products in the first year shall be determined
in accordance with the relevant rules in the National Centralized Drug Procurement Document (GY-YD2022-1) issued by the National Joint Procurement Office.
The agreed procurement volume shall be calculated and approved
by the Provincial Centralized Bidding and Procurement Center for Pharmaceuticals and Equipment based on relevant data such as relevant procurement documents and selection results.
in accordance with the relevant rules in the National Centralized Drug Procurement Document (GY-YD2022-1) issued by the National Joint Procurement Office.
The agreed procurement volume shall be calculated and approved
by the Provincial Centralized Bidding and Procurement Center for Pharmaceuticals and Equipment based on relevant data such as relevant procurement documents and selection results.
Purchase agreements are signed
once a year during the procurement cycle.
When renewing the purchase agreement, the agreed purchase quantity shall in principle not be less than the agreed purchase quantity
of the selected product in the previous year.
If the agreed purchase volume of the current year is completed in advance during the procurement cycle, the excess selected enterprises will still supply according to the selected price until the expiration
of the procurement cycle.
once a year during the procurement cycle.
When renewing the purchase agreement, the agreed purchase quantity shall in principle not be less than the agreed purchase quantity
of the selected product in the previous year.
If the agreed purchase volume of the current year is completed in advance during the procurement cycle, the excess selected enterprises will still supply according to the selected price until the expiration
of the procurement cycle.
The purchase quantity of the selected varieties is converted
If the supply specifications of the selected enterprise cannot meet the requirements of the "Procurement Variety Catalogue", the incomplete specifications of the selected varieties and incomplete specifications of the selected enterprise will not be
converted.
The procurement and supply of specific defective specifications shall be implemented
in accordance with the measures and requirements of the price linkage of defective specifications of the State Joint Procurement Office.
converted.
The procurement and supply of specific defective specifications shall be implemented
in accordance with the measures and requirements of the price linkage of defective specifications of the State Joint Procurement Office.
If the supply specifications of the selected enterprise cannot meet all the reported specifications of the variety, the agreed procurement volume of other specifications in the first year shall be multiplied and divided into the relevant selected specifications
in accordance with the conversion method and requirements of the State Joint Procurement Office.
in accordance with the conversion method and requirements of the State Joint Procurement Office.
Standby products enforce policies
According to the provisions of the "National Centralized Drug Procurement Document" (GY-YD2022-1) issued by the National Joint Procurement Office, the seventh batch of national procurement increases the backup supply mechanism, the backup enterprise is an alternative enterprise in the backup supply area, and the alternative enterprise is directly listed in the backup supply area according to the selected price, if the selected enterprise cannot supply the selected product in time and in sufficient quantity or cancels the qualification of the selected product, etc.
, resulting in the purchase and sale agreement cannot continue to be performed, the alternative enterprise can supply the corresponding
。 The provincial centralized bidding and procurement center for drugs and equipment should promptly organize Shanxi Province's spare products to be listed on
the provincial centralized procurement platform for drugs and equipment.
, resulting in the purchase and sale agreement cannot continue to be performed, the alternative enterprise can supply the corresponding
。 The provincial centralized bidding and procurement center for drugs and equipment should promptly organize Shanxi Province's spare products to be listed on
the provincial centralized procurement platform for drugs and equipment.
Under the premise of ensuring the quality of drugs and satisfying the supply of the contractually agreed procurement quantity, the selected enterprises can expand the scope of
supply according to the actual production capacity according to the selected price in centralized procurement.
supply according to the actual production capacity according to the selected price in centralized procurement.
In order to better meet the needs of the masses for medicine, expand the effect of collective procurement to benefit the people, guide the selected enterprises to increase market supply, and promote the procurement and use of drugs of reliable quality and suitable prices by medical institutions, the Provincial Centralized Bidding and Procurement Center for Pharmaceuticals and Equipment will open the authority for online procurement of selected products by medical institutions (including medical institutions with unreported volume) in the province, and the selected enterprises can expand the scope
of supply according to the actual production capacity according to the selected price of centralized procurement under the premise of ensuring the quality of drugs and meeting the procurement quantity and supply agreed in the contract.
of supply according to the actual production capacity according to the selected price of centralized procurement under the premise of ensuring the quality of drugs and meeting the procurement quantity and supply agreed in the contract.
At the same time, the selected products from other regions of the national centralized procurement are encouraged to actively apply for supply
on the platform of our province according to the selected price.
After completing the agreed procurement task, medical institutions should give priority to selecting products
with suitable prices on the provincial platform.
on the platform of our province according to the selected price.
After completing the agreed procurement task, medical institutions should give priority to selecting products
with suitable prices on the provincial platform.
Shipping method
In principle, 3 to 5 distribution companies are selected in each coordination area, and the distribution scope must cover all medical institutions participating in volume procurement; Supplier enterprises should strengthen the guarantee of distribution in remote areas, respond to medical institutions' purchase orders in a timely manner as agreed in the contract, and deliver them in place
.
.
Regulatory mechanisms
Consolidate the responsibility of the selected enterprise to ensure supply, record the selected enterprise that cannot perform the contract, substantively include it in the evaluation of the enterprise's supply capacity and performance situation, and handle it accordingly according to the severity of the circumstances
in accordance with the discretionary benchmarks for the evaluation of pharmaceutical prices and procurement credit.
in accordance with the discretionary benchmarks for the evaluation of pharmaceutical prices and procurement credit.
Medical insurance departments at all levels should strengthen the supervision of the implementation of the procurement of medical institutions in their jurisdiction, regularly report the progress of procurement, urge medical institutions to complete the agreed procurement tasks on time, and focus on warning and interviewing medical institutions that purchase non-selected drugs with high prices, so as to ensure that the results of the selection of quantity procurement are effective
.
.
Qinghai: Effective from November 1
On October 24, the Qinghai Provincial Medical Insurance Bureau issued a document clarifying that the results of the seventh batch of national procurement will be implemented from November 1, 2022, and all pharmaceutical institutions participating in centralized procurement in the province will implement them uniformly, and at the same time, the relevant implementation policies
for prepared drugs will be clarified.
for prepared drugs will be clarified.
Scope of implementation of medical institutions: public medical institutions at all levels in the province and medical institutions
of the military stationed in Qingqing.
Encourage other medical institutions and designated retail pharmaceutical enterprises of medical insurance to voluntarily participate
.
of the military stationed in Qingqing.
Encourage other medical institutions and designated retail pharmaceutical enterprises of medical insurance to voluntarily participate
.
Agreed procurement volume: The agreed procurement volume and procurement cycle of the seventh batch of selected products in the first year shall be determined
in accordance with the relevant rules in the "National Centralized Drug Procurement Document" (GY-YD2022-1) issued by the National Joint Procurement Office.
If the agreed purchase volume of the current year is completed in advance during the procurement cycle, the excess selected enterprises will still supply according to the selected price until the expiration
of the procurement cycle.
in accordance with the relevant rules in the "National Centralized Drug Procurement Document" (GY-YD2022-1) issued by the National Joint Procurement Office.
If the agreed purchase volume of the current year is completed in advance during the procurement cycle, the excess selected enterprises will still supply according to the selected price until the expiration
of the procurement cycle.
The purchase agreement is signed once a year during the procurement cycle, and when the purchase agreement is renewed, the agreed purchase quantity of the selected products shall in principle not be less than the agreed purchase quantity
of the previous year.
Primary medical institutions shall be signed
by the leading hospitals of the county medical community.
of the previous year.
Primary medical institutions shall be signed
by the leading hospitals of the county medical community.
Public medical institutions at all levels must give priority to the purchase and use of selected drugs in quantity, and while ensuring the completion of the annual agreed purchase quantity, medical institutions can combine the actual clinical use and purchase non-selected drugs of the same category at appropriate prices to meet the multi-level drug needs of
patients.
patients.
Implementation policy for backup drugs: In accordance with the provisions of the "National Centralized Drug Procurement Document" (GY-YD2022-1) issued by the National Joint Procurement Office, the seventh batch of national procurement increases the backup supply mechanism, and the products of the backup enterprises are directly listed on the network in the backup supply area according to the selected price, such as the selected enterprise cannot supply the selected products in time and in sufficient quantities or cancel the qualification of the selected products, so that the purchase and sale agreement cannot continue to be performed, the backup supply enterprise can supply the corresponding selected varieties
.
.
Regulatory regulations: The procurement of selected products, non-selected products and similar alternative products of public medical institutions at all levels will be included in the daily monitoring scope of
the system.
The results of the seventh batch of state-organized centralized drug procurement are the same as those of provincial-level or inter-provincial alliance-organized centralized drug procurement in previous years
.
the system.
The results of the seventh batch of state-organized centralized drug procurement are the same as those of provincial-level or inter-provincial alliance-organized centralized drug procurement in previous years
.
Non-selected products should fully consider the reasonable price comparison relationship with the selected products in accordance with the principle of matching efficacy and price, and guide and encourage relevant enterprises to adjust the price to a reasonable level
.
.
Guide medical institutions to implement procurement in a planned manner in accordance with the agreement, avoid large fluctuations between the actual amount and the agreed purchase amount, and at the same time prevent the phenomenon of replacing the selected products with high-priced non-selected products, and where public medical institutions do not give priority to the procurement and use of selected products, employ methods such as interviews and notifications to urge them to make timely rectifications, and handle
serious cases in accordance with relevant provisions.
serious cases in accordance with relevant provisions.
18 provinces and cities have issued documents to implement the results of the seventh batch of national collective procurement
On July 18 this year, the seventh batch of national procurement announced the results of the selection, this time the procurement of 60 drugs was successful, the average price of the selected drugs was reduced by 48%, involving 31 treatment categories, not only including hypertension, diabetes, anti-infection, digestive tract diseases and other common diseases, chronic diseases, but also lung cancer, liver cancer, kidney cancer, bowel cancer and other major diseases of drugs, according to the agreed procurement measurement, it is expected to save 18.
5 billion yuan
per year.
5 billion yuan
per year.
